Crossmark

Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months

Crossref DOI link: https://doi.org/10.1038/s41372-021-01047-0

Published Online: 2021-03-26

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reis, Jordan D.

Tolentino-Plata, Kristine

Heyne, Roy

Brown, L. Steven

Rosenfeld, Charles R. https://orcid.org/0000-0002-9208-6539
Caraig, Maria

Burchfield, Patti J.

Brion, Luc P. https://orcid.org/0000-0002-6139-0132
Funding

Funding for this research was provided by:

UT Southwestern Medical Center: George L. MacGregor Professorship

Children’s Medical Center at Dallas
License Information

Text and Data Mining valid from 2021-03-26

Version of Record valid from 2021-03-26
More Information

Article History

Received: 22 January 2021

Revised: 25 February 2021

Accepted: 11 March 2021

First Online: 26 March 2021

Compliance with ethical standards

:

: The authors declare no competing interests.

: The original QI project, including follow-up, received approval by the Institutional Review Board (IRB) of the University of Texas Southwestern Medical Center, Parkland Health and Hospital Systems and Children’s Medical Center. Informed consent was obtained for all infants in the study who had follow-up at the Thrive clinic.

Document is current

Any future updates will be listed below